ArticleMolecular cancer therapeutics2022

DS-7300a, a DNA Topoisomerase I Inhibitor, DXd-Based Antibody-Drug Conjugate Targeting B7-H3, Exerts Potent Antitumor Activities in Preclinical Models.

Michiko Yamato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.